Literature DB >> 8492105

Evidence of persistent measles virus infection in Crohn's disease.

A J Wakefield1, R M Pittilo, R Sim, S L Cosby, J R Stephenson, A P Dhillon, R E Pounder.   

Abstract

Transmission electron microscopy was used to examine the microvasculature of perfusion-fixed tissues from Crohn's disease and control patients. Paramyxovirus-like particles, and inclusions consisting of condensations of nucleocapsid, in giant cells and endothelium at foci of vascular injury were identified in all 9 Crohn's disease patients. Tissues from patients with Crohn's disease were also examined by either in situ hybridisation (n = 10) or immunohistochemistry (n = 15), and compared to inflammatory and noninflammatory controls (n = 22). Hybridisation for measles virus N-protein genomic RNA was positive in all cases of Crohn's disease localising to foci of granulomatous vasculitis and lymphoid follicles. Positive immunohistochemical staining for measles virus nucleocapsid protein was positive in 13 of 15 patients with Crohn's disease, localising to foci of granulomatous inflammation. Hybridisation for measles virus RNA was positive in a minority of control intestinal tissues; viral inclusions were not seen ultrastructurally. Immunostaining was negative in control cases of intestinal tuberculosis. These observations suggest that measles virus is capable of causing persistent infection of the intestine and that Crohn's disease may be caused by a granulomatous vasculitis in response to this virus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8492105     DOI: 10.1002/jmv.1890390415

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  51 in total

1.  No evidence of persistent mumps virus infection in inflammatory bowel disease.

Authors:  M Iizuka; H Saito; M Yukawa; H Itou; T Shirasaka; M Chiba; T Fukushima; S Watanabe
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study.

Authors:  D Ludwig; S Wiener; A Brüning; K Schwarting; G Jantschek; K Fellermann; M Stahl; E F Stange
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

3.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

4.  MMR vaccine--worries are not justified.

Authors:  D A Elliman; H E Bedford
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 5.  Detection of persistent measles virus infection in Crohn's disease: current status of experimental work.

Authors:  S Ghosh; E Armitage; D Wilson; P D Minor; M A Afzal
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

6.  Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine.

Authors:  B Thjodleifsson; K Davídsdóttir; U Agnarsson; G Sigthórsson; M Kjeld; I Bjarnason
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

7.  Measles virus serology in Crohn's disease.

Authors:  N C Fisher; L Yee; P Nightingale; R McEwan; J A Gibson
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

8.  Direct in situ nucleic acid amplification: control of artefact and use of labelled primers.

Authors:  R Ray; R Sim; K Khan; P Cooper; R Pounder; A Wakefield
Journal:  Clin Mol Pathol       Date:  1996-12

Review 9.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

10.  Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha.

Authors:  P E Watkins; B F Warren; S Stephens; P Ward; R Foulkes
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.